Duoning Biotech Seeks Hong Kong Listing; WUXI BIO is Its Largest Client
Company Listing: Shanghai Duoning Biotechnology has submitted a listing application to the Hong Kong Stock Exchange, with Morgan Stanley and Huatai International as joint sponsors.
Clientele and Services: The company provides bioprocess solutions and laboratory products to pharmaceutical companies, CROs, CDMOs, and research institutions, with major clients including top biopharmaceutical firms in China.
Key Clients: WuXi Biologics is highlighted as one of the largest clients and suppliers, along with other notable shareholders such as CSPC Pharma, Akeso, and Keymed Bio-B.
Market Activity: The article notes short selling activity and stock performance for several companies in the sector, indicating market dynamics and investor interest.
Get Free Real-Time Notifications for Any Stock
Analyst Views on 01093
About the author
CSPC Pharma Collaborates with AstraZeneca on Long-Acting Peptide Medicines, Securing Over $9.3B Upfront Payment, Despite 10% Drop in Share Price
CSPC Pharma Collaboration: CSPC Pharma has entered a strategic collaboration with AstraZeneca for developing long-acting peptide medicines, leveraging its proprietary technology and AI-driven drug discovery platform.
Financial Terms: The agreement includes an upfront payment of $1.2 billion, with potential additional payments of up to $3.5 billion for R&D milestones and $13.8 billion for sales milestones, plus royalties on net sales.
Stock Performance: Following the announcement, CSPC Pharma's stock opened 2.34% higher but later fell by 10.1%, closing at $9.61 with significant trading volume.
Short Selling Activity: CSPC Pharma has reported short selling of $160.35 million, with a short selling ratio of 14.568%.
<Full-day Summary> HSI Gains 361 Points; HSTI Rises 28 Points; CHINA LIFE Surges Over 5%; CHINA LIFE, AIA, HSBC HOLDINGS, CHINAHONGQIAO, WH GROUP Reach New Peaks; Market Turnover Increases
Market Performance: The Hang Seng Index (HSI) rose by 361 points (1.4%) to close at 27,126, with a total market turnover of $254.37 billion.
Active Heavyweights: Notable stocks included Alibaba (+2.8%), Ping An (+2.3%), and Tencent (+1.3%), while Meituan saw a decline of 0.6%.
Constituents on the Move: China Life surged by 6% to a new high, while Hang Lung Properties and Hansoh Pharma experienced significant declines of 4.5% and 4.4%, respectively.
Short Selling Activity: High short selling ratios were observed in several stocks, with Hansoh Pharma at 39.5% and Meituan at 27.4%, indicating investor caution.
